How to appraise the effectiveness of treatment

World Journal of Surgery

Volumn 29, Issue 5, 2005, Pages 570-575

  Bhandari, Mohit ^a,b   Haynes, R Brian ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CONFERENCE PAPER; FOLLOW UP; HUMAN; MEDICAL DECISION MAKING; RISK FACTOR; RISK REDUCTION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EVALUATION STUDIES; EVIDENCE-BASED MEDICINE; GAMMA-AMINOBUTYRIC ACID; GUIDELINES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 23944466691     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-005-7915-9     Document Type: Conference Paper

References (20)

1. GH Guyatt D Rennie 2001 American Medical Association: User's Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice 2 American Medical Association Press Chicago
2. DL Sackett RB Haynes GH Guyatt 1991 Clinical Epidemiology: A Basic Science for Clinical Medicin 2 Little, Brown Boston
3. JP Ioannidis AB Haidich M Pappa 2001 Comparison of evidence of treatment effects in randomized and nonrandomized studies J.A.M.A 286 821 830
4. R Kunz AD. Oxman 1998 The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials B.M.J. 317 1185 1190
5. RB Haynes J Mukherjee DL Sackett 1987 Functional status changes following medical or surgical treatment for cerebral ischemia: results in the EC/IC Bypass Study J.A.M.A. 257 2043 2046
6. TC Chalmers P Celano HS Sacks 1983 Bias in treatment assignment in controlled clinical trials N. Engl. J. Med 309 1358 1361
7. JB Hansen BM Smithers D Schache 1996 Laparoscopic versus open appendectomy: prospective randomized trial World J. Surg. 20 17 20
8. KF Schulz I Chalmers RJ Hayes 1995 Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials J.A.M.A. 273 408 412
9. D Moher A Jones DJ Cook 1998 Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352 609 613
10. Coronary Drug Project Research Group 1980 Influence of adherence treatment, response of cholesterol on mortality in the Coronary Drug Project N. Engl. J. Med 303 1038 1041
11. GE Hogarty SC. Goldberg 1973 Drug and sociotherapy in the aftercare of schizophrenic patients Arch. Gen. Psychiatry 28 54 64
12. PJ Devereaux BJ Manns W Ghali 2001 In the dark: physician interpretations and textbook definitions of blinding terminology in randomized controlled trials J.A.M.A. 285 2000 2003
13. VM Montori M Bhandari PJ Devereaux 2002 In the dark: the reporting of blinding status in randomized controlled trials J. Clin. Epidemiol. 55 42 45
14. M Bhandari R Richards EH. Schemitsch 2002 The quality of randomized trials in Journal of Bone, Joint Surgery from 1988-2000 J. Bone Joint Surg Am. 84A 388 396
15. GH Guyatt SO Pugsley MJ Sullivan 1984 Effect of encouragement on walking test J performance Thorax 39 818 822
16. AS Detsky DL. Sackett 1985 When was a "negative" trial big enough? How many patients you needed depends on what you found Arch Intern Med 145 709 715
17. DA Savitz AF. Olshan 1995 Multiple comparisons, related issues in the interpretation of epidenuological data Am. J. Epidemiol. 142 904 908
18. AD Oxman GH. Guyatt 1992 A consumer's guide to subgroup analysis Ann. Intern Med. 116 78 84
19. SF Assman SJ Pocock LE Enos 2000 Subgroup analyses and other (mis)uses of baseline data in clinical trials Lancet 355 1064 1069
20. M Bhandari GH Guyatt D Tong 2004 Reamed versus non-reamed intramedullary nailing of lower extremity long bone fractures: a systematic overview and meta-analysis J. Orthop. Trauma 14 2 9